It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for approval by the FDA. How promising is this drug’s impact? Its testing is being called a watershed moment in cancer treatment. Dr. Bijoy Telivala, an oncologist with Cancer Specialists of North Florida, joined News4Jax anchor Bruce Hamilton to discuss this new drug that can double the survival rate in patients with an advanced form of pancreatic cancer.